z-logo
open-access-imgOpen Access
MP72-19 PHASE II STUDY OF AXITINIB FOR DOWNSTAGING CT2A TO CT1 RENAL TUMORS FOR ALLOWING PARTIAL NEPHRECTOMY (AXIPAN)
Author(s) -
C. Lebâcle,
JeanChristophe Bernhard,
Karim Bensalah,
Hervé Baumert,
Hervé Lang,
Didier Jacqmin,
Brigitte Duclos,
Alain Ravaud,
Brigitte Laguerre,
Laurence Albigès,
Armelle Arnoux,
Bernard Escudier,
Jean Jacques Patard
Publication year - 2017
Publication title -
the journal of urology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.402
H-Index - 256
eISSN - 1527-3792
pISSN - 0022-5347
DOI - 10.1016/j.juro.2017.02.2255
Subject(s) - nephrectomy , axitinib , medicine , urology , cancer , kidney , sunitinib

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom